Volume 13, Issue 3, March 2021

Highlight

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
Cheng Wan, Chun Zhang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 159-160, https://doi.org/10.1093/jmcb/mjab006
Abstract | Full Text 

Reviews

COVID-19 and cardiovascular diseases
Fan Liu, Feng Liu, Lu Wang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 161-167, https://doi.org/10.1093/jmcb/mjaa064
Abstract | Full Text 
Entry, egress and vertical transmission of SARS-CoV-2
Hui Zhang, Hong Zhang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 168-174, https://doi.org/10.1093/jmcb/mjab013
Abstract | Full Text 
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology
Dania Altulea, Sjors Maassen, Maksim V. Baranov, G. van den Bogaart
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 175-184, https://doi.org/10.1093/jmcb/mjab016
Abstract | Full Text 

Articles

Kidney injury molecule-1 is a potential receptor for SARS-CoV-2
Chen Yang, Yu Zhang, Xia Zeng, Huijing Chen, Dong Yang, Yuchen Chen, Ziwei Shen, Xiaomu Wang, Xinran Liu, Mingrui Xiong, Hong Chen, Kun Huang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 185-196, https://doi.org/10.1093/jmcb/mjab003
Abstract | Full Text 
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
Jingyi Yang, Maohua Zhong, Ejuan Zhang, Ke Hong, Qingyu Yang, Dihan Zhou, Jianbo Xia, Yao-Qing Chen, Mingbo Sun, Bali Zhao, Jie Xiang, Ying Liu, Yang Han, Mengxin Xu, Xi Zhou, Chaolin Huang, You Shang, Huimin Yan
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 197-209, https://doi.org/10.1093/jmcb/mjab014
Abstract | Full Text 
Ablation of Zfhx4 results in early postnatal lethality by disrupting the respiratory center in mice
Meiqin Zhang, Sichen Du, Huayuan Ou, Renjie Cui, Nan Jiang, Yifeng Lin, Runsheng Ge, Duan Ma, Jin Zhang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 210-224, https://doi.org/10.1093/jmcb/mjaa081
Abstract | Full Text 

Letter to the Editor

Short sequence motif dynamics in the SARS-CoV-2 genome suggest a role for cytosine deamination in CpG reduction
Mukhtar Sadykov, Tobias Mourier, Qingtian Guan, Arnab Pain
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 225-227, https://doi.org/10.1093/jmcb/mjab011
Abstract | Full Text 

Application Note

Investigation and analysis of psychological stress among non-severe COVID-19 patients
Xiangmin Liu, Feng Wang, Huanhuan Li, Yaozhi Zhang, Lan Luo, Jiajia Dong, Xi Xiang, Jinqiu Cao, Ting Wu, Miao Xue, Jiqiang Zhang
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 228-231, https://doi.org/10.1093/jmcb/mjab009
Abstract | Full Text 

Perspective

Available drugs and supplements for rapid deployment for treatment of COVID-19 
Danielle Cicka, Vikas P. Sukhatme
J Mol Cell Biol, Volume 13, Issue 3, March 2021, 232-236, https://doi.org/10.1093/jmcb/mjab002
Abstract | Full Text 
Cover: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rages during the winter, when the humidity and temperature are both low. The cardiovascular system can be severely affected after SARS-CoV-2 infection. The expression of angiotensin-converting enzyme 2 (ACE2) in the cardiovascular system predisposes it to SARS-CoV-2. In addition, cytokine storm caused by the overloaded inflammatory factors, including interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a), which are produced by the anti-virus response, may also contribute to the impairment of the cardiovascular system. See page 161–167 by Liu et al. for details.